Document is current

Article History

Received: 31 July 2024

Accepted: 24 April 2025

First Online: 2 May 2025

Declarations

:

: The ADJUSST study was approved by the Advarra® Institutional Review Board (IRB). All participants provided written informed consent and were compensated $30 for each survey completed, without respect to their smoking or JUUL use.

: Not applicable.

: This study was sponsored by JUUL Labs, Inc (JLI), and the preparation of this manuscript was supported by JLI. Authors AS, SK, and SS are affiliated with Pinney Associates, Inc. (PA). Since October 2019, PA has been and continues to consult to JLI on nicotine vapor products to advance tobacco harm reduction. In addition, in the past 3 years, Pinney Associates has consulted to Philip Morris International (PMI) solely on US regulatory pathways for non-combustible, non-tobacco, nicotine products. PA does not consult on combustible tobacco products. AS also individually provides consulting services on behavioral science to the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) through ECLAT Srl, which received funding from the Foundation for a Smoke-Free World (FSFW; now the Global Action to End Smoking (GA)). Author NG is an employee of JLI. JLI reviewed and provided comments on a near-final draft of the manuscript. Neither PMI, CoEHAR, nor FSFW/GA had any role in, or oversight of, this manuscript.